CD274 and idiopathic pulmonary fibrosis: These case reports of NSCLC patients are however not really suited to study the role of PD-1/PD-L1 inhibition in pulmonary fibrosis and future clinical trials should elucidate whether the PD-1/PD-L1 axis holds promise in IPF.